Anthony Langone
Last active: 4/3/2014

  1. Does reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry. Langone A, Doria C, Greenstein S, Narayanan M, Ueda K, Sankari B, Pankewycz O, Shihab F, Chan L (2013) Clin Transplant 27(1): 15-24
    › Primary publication · 22861144 (PubMed) · PMC3593178 (PubMed Central)
  2. Mammalian target of rapamycin inhibitors in organ transplantation: an unkept promise. Langone AJ, Helderman JH (2012) Chest 142(3): 734-737
    › Primary publication · 22948577 (PubMed)
  3. Enteric-coated mycophenolate sodium versus mycophenolate mofetil in renal transplant recipients experiencing gastrointestinal intolerance: a multicenter, double-blind, randomized study. Langone AJ, Chan L, Bolin P, Cooper M (2011) Transplantation 91(4): 470-8
    › Primary publication · 21245794 (PubMed)
  4. Renal donation after cardiac death. Shah N, Langone A (2010) J Am Soc Nephrol 21(6): 888-90
    › Primary publication · 20488957 (PubMed)
  5. Recurrent pauci-immune necrotizing crescentic glomerulonephritis in a kidney transplant patient. Schaefer HM, Langone A, Helderman JH, Fogo AB (2010) Am J Kidney Dis 55(3): 604-8
    › Primary publication · 19782451 (PubMed)
  6. mTOR inhibitor-associated dermatologic and mucosal problems. Campistol JM, de Fijter JW, Flechner SM, Langone A, Morelon E, Stockfleth E (2010) Clin Transplant 24(2): 149-56
    › Primary publication · 20236129 (PubMed)
  7. Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients. Bolin P, Tanriover B, Zibari GB, Lynn ML, Pirsch JD, Chan L, Cooper M, Langone AJ, Tomlanovich SJ (2007) Transplantation 84(11): 1443-51
    › Primary publication · 18091520 (PubMed)
  8. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors. Chuang P, Langone AJ (2007) Am J Ther 14(5): 438-41
    › Primary publication · 17890931 (PubMed)
  9. Ezetimibe in renal transplant patients with hyperlipidemia resistant to HMG-CoA reductase inhibitors. Langone AJ, Chuang P (2006) Transplantation 81(5): 804-7
    › Primary publication · 16534487 (PubMed)
  10. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Chuang P, Parikh CR, Langone A (2005) Clin Transplant 19(2): 230-5
    › Primary publication · 15740560 (PubMed)